Viewing nowBiltax Tablet 50 mg (Vildagliptin)
Vildagliptin 50mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.

MFDS item code 202102037 · Approved 2021.03.04 · Insurance code 690303400
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar in patients with type 2 diabetes. It can be taken alone or in combination with other medications, alongside diet and exercise therapy. This helps to effectively manage blood sugar levels and improve diabetes symptoms.
When used as monotherapy or in combination with metformin in patients with no prior experience of antidiabetic drug treatment, this medicine is administered at 50mg once daily in the morning, or at 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with metformin or thiazolidinedione monotherapy, the recommended dose when this medicine is used in combination with metformin or a thiazolidinedione is 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with sulfonylurea monotherapy, the recommended dose when this medicine is used in combination with a sulfonylurea is 50mg once daily in the morning. In this patient population, vildagliptin 100mg once daily was not more effective than 50mg once daily. When adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose when this medicine is used as an add-on (third-line therapy) is 100mg per day, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose when this medicine is used in combination is 100mg per day, divided into 50mg twice daily in the morning and evening. This medicine may be taken with or without food, and doses greater than 100mg per day are not recommended. When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you miss a dose of this medicine, take it as soon as you remember and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment Use is not recommended in patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment with this medicine. Patients with renal impairment Mild renal impairment (creatinine clearance ≥50mL/min): No dose adjustment is necessary. Moderate or severe renal impairment, or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended. (See Precautions for Use, ‘3. General Precautions,’ item 2)
This medication should not be used in certain patients. Individuals who are allergic to the active ingredient or any other components should not take it. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Additionally, since it contains lactose, it should not be used in patients with lactose intolerance or certain genetic disorders. During the use of this medication, liver function abnormalities may rarely occur, so regular liver function tests should be performed. If liver enzymes significantly exceed normal ranges, the medication should be discontinued. If symptoms of hepatitis or jaundice appear, discontinue use immediately and consult a physician. This medication can cause hypoglycemia, especially when taken with sulfonylureas, increasing the risk. Therefore, if taken with such medications, be vigilant for symptoms of hypoglycemia and dosage adjustments may be required. During the course of this medication, symptoms such as dizziness, headache, dyspepsia, and constipation may occur; if symptoms are severe or persistent, consult with healthcare professionals. There is a risk of acute pancreatitis, so if symptoms such as abdominal pain, vomiting, or loss of appetite occur, you should visit a hospital immediately. If pancreatitis is confirmed, this medication should be discontinued and not be re-administered. This medication is not recommended for pregnant or breastfeeding women. The safety in pregnant women has not been established, and safety has not been confirmed in breastfeeding women. Elderly patients (65 years or older) do not require special dosage adjustment, but it is advisable to avoid using it in children and adolescents (under 18 years of age) as safety and effectiveness have not been established. In cases of overdose, there is no specific antidote, so supportive treatment will be done based on symptoms, and this medication itself cannot be removed by hemodialysis. Caution is necessary when driving or operating machinery. Symptoms such as dizziness or drowsiness may occur after ingestion, so it is advisable to avoid driving in such cases. If unusual symptoms such as blisters or ulcers on the skin appear, inform healthcare providers immediately, and the medication should be discontinued and discussed with a specialist if necessary. Interactions with other medications are unlikely, but blood sugar control may be reduced when taken with certain medications, so it is important to consult a physician or pharmacist regarding any other current medications. This medication should be kept out of reach of children and transferring it to other containers may impair quality, so caution is advised.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its effectiveness.
Round tablet with a white to light yellow color
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowVildagliptin 50mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Ahn-Guk New Pharm Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
AhnGuk Pharmaceuticals Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
White Life Sciences Co., Ltd.
Vildagliptin 50mg
Tablet · Prescription medication
Pharmgen Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.